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Background
Deregulation of focal adhesion (FA) dynamics has been
found to contribute to tumour progression by promoting
cancer cell migration and invasion. Both focal adhesion
kinase (FAK) and Src are involved in FA formation, and
both interact with the scaffolding protein ezrin, which
our group has shown to be required for breast cancer
metastasis. Our aim was to assess the role of the mem-
brane-cytoskeletal linker protein ezrin in Src-induced
adhesion and migration in the human invasive breast
cancer cell line MDA-MB-231.
Materials and methods
shRNA-mediated knockdown (KD) of ezrin function was
conducted in MDA-MB-231 cells, as well as in cells
expressing constitutively active Src (MDA-Src). Adhesion
and migration were assessed using collagen-I adhesion
assays and wound healing assays, respectively. Expression
and localization of FA proteins was assessed via immuno-
blotting and immunofluorescence (IF).
Results
Ezrin KD impaired migration of both MDA-MB-231 and
MDA-Src cells. Interestingly, Ezrin KD resulted in
increased cell adhesion to collagen-I, an extracellular
matrix protein found in stromal tissue. IF imaging of the
FA-associated proteins b1 integrin, FAK, paxillin, and vin-
culin revealed an increase in localization of these proteins
to FA sites at the cell periphery in ezrin KD cells com-
pared to control cells. Furthermore, immunoblotting ana-
lysis showed increases in protein expression of b1 integrin,
FAK and paxillin but not vinculin, suggesting that FA
formation may be increased when ezrin expression is
abolished.
Conclusions
Ezrin is required for adhesion and migration of MDA-
MB-231 cells, and may play an important regulatory role
in FA dynamics.
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